Akanda Corp Market Cap ($584.11K)
Market Cap & Net Worth: Akanda Corp (AKAN)
Akanda Corp market cap. Akanda Corp (NASDAQ:AKAN) has a market capitalization of $584.11K ($584.11K) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30986 globally and #6291 in its home market, demonstrating a 2.86% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Akanda Corp's stock price $1.08 by its total outstanding shares 540841 (540.84K). Also see Akanda Corp cash flow conversion for how efficiently the company converts equity into cash flow.
Akanda Corp Market Cap History (2022–2026)
Akanda Corp market cap history from 2022 to 2026. Data shows change from $64.47 Million to $584.11K (-85.49% CAGR). Check AKAN stock price for real-time trading data and today's change.
Index Memberships
Akanda Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #909 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2869 of 3165 |
Weight: Akanda Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Akanda Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Akanda Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Akanda Corp equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.96x
Akanda Corp's market cap is 0.96 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $64.47 Million | $2.62 Million | -$11.66 Million | 24.61x | N/A |
| 2023 | $19.06 Million | $2.16 Million | -$32.28 Million | 8.82x | N/A |
| 2024 | $865.35K | $836.66K | -$4.10 Million | 1.03x | N/A |
| 2025 | $247.33K | $258.07K | -$45.65 Million | 0.96x | N/A |
Competitor Companies of AKAN by Market Capitalization
Companies near Akanda Corp in the global market cap rankings as of November 4, 2026. Also see Akanda Corp assets under control for a full breakdown of the balance sheet.
Key companies related to Akanda Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Akanda Corp (2022–2026)
Market capitalization of Akanda Corp from 2022 to today. Between 2022 and today, Akanda Corp's market cap moved from $64.47 Million to $ 584.11K, with a yearly change of -85.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $584.11K | +136.17% |
| 2025 | $247.33K | -71.42% |
| 2024 | $865.35K | -95.46% |
| 2023 | $19.06 Million | -70.44% |
| 2022 | $64.47 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Akanda Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $584.11K USD |
| MoneyControl | $584.11K USD |
| MarketWatch | $584.11K USD |
| marketcap.company | $584.11K USD |
| Reuters | $584.11K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Akanda Corp
Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.